期刊文献+

细胞外基质金属蛋白酶诱导因子和基质金属蛋白酶-2在喉癌中的表达

Expression of EMMPRIN and Matrix Metalloproteinase-2 in Laryngeal Carcinoma
下载PDF
导出
摘要 目的 了解细胞外基质金属蛋白酶诱导因子 (EMMPRIN )和基质金属蛋白酶 2 (MMP 2 )在喉癌的表达情况 ,探讨两者表达的关系以及与喉癌浸润和转移的关系。方法 采用免疫组织化学S P法对 47例喉癌和 2 2例正常喉组织中的EMMPRIN和MMP 2的表达情况进行检测。结果 EMMPRIN和MMP 2在喉癌的阳性表达率 (分别为 87.2 %和 91.5 % )明显高于正常喉组织分别为 ( 9.1%和 18.2 % ) ,EMMPRIN和MMP 2的强阳性表达与喉癌的病理分级、临床分期和淋巴结转移情况有关 ;EMM PRIN和MMP 2的表达一致率为 91.5 % ,Kappa值为 0 .614 ,两者表达具有明显的相关性。 结论 EMMPRIN和MMP 2在喉癌有阳性表达 ,表达与喉癌的临床分期和淋巴结转移有关 ,EMMPRIN与MMP Objective To investigate the expression of extracellular matrix metalloproteinase inducer(EMMPRIN) and matrix metalloproteinase-2 in human laryngeal carcinoma,and to study its relationship with the invasion and the metastasis.Methods The expression of EMMPRIN and MMP-2 was detected by immunohistochemical S-P in 47 specimens from laryngeal carcinoma and 22 specimens from normal laryngeal.Results The positive expression rates of EMMPRIN and MMP-2 were significantly higher in laryngeal carcinoma than in normal laryngeal tissues(87.2% vs.9.1%,91.5% vs.18.2%).The strong expression rates of EMMPRIN and MMP-2 had a positive relationship with histopathological grade,clinical stage and the situation of lymph nodes matastases.Significant correlation was found between the expression of EMMPRIN and MMP-2.Conclusion The expression of EMMPRIN and MMP-2 relates to the clinical stage and lymph nodes matastases of laryngeal carcinoma.Increased MMP-2 might be induced by EMMPRIN expressed in laryngeal tumor cells.
出处 《实用癌症杂志》 2004年第3期279-282,共4页 The Practical Journal of Cancer
关键词 细胞外基质 金属蛋白酶 诱导因子 基质金属蛋白酶-2 喉癌 基因表达 肿瘤 Laryngeal carcinoma Extracellular matrix metalloproteinase inducer(EMMPRIN) Matrix metalloproteinase-2(MMP-2) Immunohistochemistry
  • 相关文献

参考文献12

  • 1Curran S,Murray GI.Matrix metalloproteinases in tumour invasion and metastasis[J].J Pathol,1999,189(3):300.
  • 2Biswas C,Zhang Y,DeCastro R,et al.The human tumor cell-derived collagenase stimulatory factor(renamed EMMPRIN) is a member of the immunoglobulin superfamily[J].Cancer Res,1995,55(2):434.
  • 3Werner J,Rathcke I,Mandic R.The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck[J].Clin Exp Metastasis,2002,19(4):275.
  • 4Schutz A,Schneidenbach D,Aust G,et al.Differential expression and activity status of MMP-1,MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung[J].Tumour Biol,2002,23(3):179.
  • 5Ellis S,Nabeshima K,Biswas C.Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor[J].Cancer Res,1989,49(12):3385.
  • 6Sun J,Hemler ME.Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions[J].Cancer Res,2001,61(5):2276.
  • 7Caudroy S,Polette M,Nawrocki-Raby B,et al.EMMPRIN-mediated MMP regulation in tumor and endothelial cells[J].Clin Exp Metastasis,2002,19(8):697.
  • 8Dalberg K,Eriksson E,Enberg U.Gelatinase A,membrane type 1 matrix metalloproteinase,and extracellular matrix metalloproteinase inducer mRNA expression:correlation with invasive growth of breast cancer[J].World J Surg,2000,24:(3)343.
  • 9王贤辉,郭晓楠,陈志南.肝癌膜相关抗原HAb18G的提纯及功能鉴定[J].肿瘤防治研究,2001,28(4):262-263. 被引量:1
  • 10Bordador LC,Li X,Toole B,et al.Expression of emmprin by oral squamous cell carcinoma[J].Int J Cancer,2000,85(3):347.

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部